[1] Doumas BT, Wu TW. The measurement of bilirubin fractions in serum[J]. Crit Rev Clin Lab Sci, 1991, 28(5-6):415-445. [2] Fevery J. Bilirubin in clinical practice:a review[J]. Liver Int, 2008, 28(5):592-605. [3] Kunutsor SK, Bakker SJ, Gansevoort RT, et al. Circulating total bilirubin and risk of incident cardiovascular disease in the general population[J]. Arterioscl Throm Vas Biol, 2015, 35(3):716-724. [4] Zhang XJ, Sun TW, Kan QC, et al. Serum total bilirubin and long-term outcome in patients undergoing percutaneous coronary intervention[J]. Clin Invest Med, 2014, 37(5):E345-351. [5] Cervellin G, Buonocore R, Sanchis-Gomar F, et al. Low serum bilirubin values are associated with pulmonary embolism in a case-control study[J]. Clin Chem Lab Med, 2016, 54(8):e229-230. [6] Rodrigo R, Fernandez-Gajardo R, Gutierrez R, et al. Oxidative stress and pathophysiology of ischemic stroke:novel therapeutic opportunities[J]. CNS Neurol Disord Drug Targets, 2013, 12(5):698-714. [7] 刘力生, 王文, 姚崇华. 中国高血压防治指南(2009 年基层版)[J]. 中华高血压杂志, 2010, 18(1):11-30. [8] 中华医学会糖尿病学分会. 中国 2 型糖尿病防治指南(2010年版)[J]. 中国医学前沿杂志, 2011, 3(6):54-109. [9] Orhan G, Elkama A, Mungan SO, et al. The impact of detoxifying and repair gene polymorphisms on oxidative stress in ischemic stroke[J]. Neurol Sci,2016, 37(6):955-961. [10] 赵晓琴. 胆红素抗氧化作用及其与冠心病关系的研究进展[J]. 实用心脑肺血管病杂志, 2015, 23(1):141-143. [11] Lin JP, Vitek L, Schwertner HA. Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease[J]. Clin Chem, 2010,56(10):1535-1543.